Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2122995 | European Journal of Cancer | 2011 | 9 Pages |
Abstract
We conclude that elevated serum angiogenin surfaced as an independent predictor for failure in long-term treatment response and for poor overall survival in a series of 204 NHL patients, and might thus also complement the IPI in identifying the patients with particularly aggressive and/or treatment resistant disease.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Shentong Fang, Heikki Repo, Heikki Joensuu, Arto Orpana, Petri Salven,